New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy

doi:10.3748/wjg.v27.i48.8357

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4409)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

236

WORD

110

HTML

1744

Figures (1-3)

185

Tables (1-3)

190

Sum=2465

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

422

Download

535

Sum=957

Publishing Process of This Article

Item

Count

Browse

334

Download

653

Sum=987

Dec 28, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 28, 2021; 27(48): 8357-8369
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8357

Full Size Figure Download Figure

Figure 3 Decision curve analysis curves and time-dependent receiver operating characteristic curves for the nomogram in the validation set. A: The calculated net benefit (Y-axis) corresponds to the threshold probability of survival on the X-axis; B: The time-dependent receiver operating characteristic curve assesses the accuracy of the nomogram. ALP: Alkaline phosphatase; NLR: Neutrophil-lymphocyte ratio; ECOG PS: Eastern Cooperative Oncology Group performance score.

Citation: Koo DH, Ryu MH, Lee MY, Moon MS, Kang YK. New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy. World J Gastroenterol 2021; 27(48): 8357-8369
URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8357.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8357